Method for selectively producing ginsenoside Rd from saponins of ginseng through enzymatic method

US10519480B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10519480-B2
Application numberUS-201615769995-A
CountryUS
Kind codeB2
Filing dateOct 21, 2016
Priority dateOct 22, 2015
Publication dateDec 31, 2019
Grant dateDec 31, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method for selectively producing ginsenoside Rd, which is originally present in ginseng in a trace amount, from panaxadiol-type saponins of ginseng, and more specifically to a method capable of obtaining a desired target compound, that is, ginsenoside Rd, in high yields, by treating a panaxadiol-type saponin obtained from ginseng, with particular enzymes to structurally convert the saponins.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing ginsenoside Rd of the following chemical formula 1 from ginsenoside Rb1, said method comprising contacting a substrate comprising ginsenoside Rb1 with pectinase obtained from Trichoderma reesei thereby converting the ginsenoside Rb1 to ginsenoside Rd: 2. The method according to claim 1 , wherein the substrate comprising ginsenoside Rb1 is a ginseng saponin. 3. The method according to claim 2 , wherein the method comprises the steps of: 1) contacting the ginseng saponin in an aqueous solvent or a mixed solution of an aqueous solvent and an organic solvent with the pectinase, and allowing the converting undergoes thereby producing a reaction mixture comprising ginsenoside Rd as a conversion product; 2) inactivating the pectinase in the reaction mixture of 1) thereby completing the conversion reaction; and 3) adding ethyl acetate or ethanol to the reaction mixture obtained in 2), followed by extraction and concentration, thereby isolating ginsenoside Rd. 4. The method according to claim 1 , wherein the pectinase is added in an amount of 10 to 400% by weight based on the amount of the substrate. 5. The method according to claim 1 , wherein the converting of 1) is carried out at a temperature of 35 to 60° C. 6. The method according to claim 3 , wherein the converting of 1) is carried out for 1 to 48 hours. 7. The method according to claim 3 , wherein the aqueous solvent or the mixed solution of an aqueous solvent and an organic solvent has a pH in the range of 3.5 to 5.5.

Assignees

Inventors

Classifications

  • Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals · CPC title

  • Preparation of O-glycosides, e.g. glucosides {(polysaccharides and not substituted disaccharides C12P19/04, C12P19/12)} · CPC title

  • Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton (cardanolide, bufanolide C07J19/00) · CPC title

  • C12P33/16Primary

    Acting at 17 position · CPC title

  • Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10519480B2 cover?
The present invention relates to a method for selectively producing ginsenoside Rd, which is originally present in ginseng in a trace amount, from panaxadiol-type saponins of ginseng, and more specifically to a method capable of obtaining a desired target compound, that is, ginsenoside Rd, in high yields, by treating a panaxadiol-type saponin obtained from ginseng, with particular enzymes to st…
Who is the assignee on this patent?
Amorepacific Corp
What technology area does this patent fall under?
Primary CPC classification C12P33/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).